November 16, 15:12
Foreground
Modern vaccine, storage at standard temperatures
Photo story
© ANSA / EPA
SEE PHOTOSTORY Photos
Close
© ANSA / EPA
Close
Coronavirus disease (COVID-19) vaccine prodcution in Switzerland © ANSA / EPA
Close
Coronavirus disease (COVID-19) vaccine prodcution in Switzerland © ANSA / EPA
Close
Moderna Inc. announces Covid-19 vaccine, 95 percent effective © ANSA / EPA
Close
Biotech firm Moderna in Norwood Massachusetts © ANSA
Close
Coronavirus disease (COVID-19) vaccine prodcution in Switzerland © ANSA / EPA
Close
Coronavirus disease (COVID-19) vaccine prodcution in Switzerland © ANSA / EPA
Close
Moderna Inc. announces Covid-19 vaccine, 95 percent effective © ANSA / EPA
Close
Coronavirus disease (COVID-19) vaccine prodcution in Switzerland © ANSA / EPA
(ANSA) - ROME, NOVEMBER 16 - The Moderna company has announced a longer shelf life for its candidate vaccinomRNA-1273 against COVID-19 at "refrigeration temperatures".
The vaccine candidate is expected to remain stable at standard refrigeration temperatures between 2 ° and 8 ° C for 30 days, compared to the previous estimate of 7 days.
In addition, transport and long-term storage conditions are provided at standard freezer temperatures of -20 ° C for 6 months.
The company announced it.
(HANDLE).
Share
Suggest
Facebook
Twitter
Linkedin
Mail
Code to embed
Get the embed code
REPRODUCTION RESERVED © Copyright ANSA